Author:
Ripamonti Diego,Tatarelli Paola,Mangili Giovanna,Gotta Cristina,Benatti Simone V.,Bruzzone Bianca,Callegaro Anna,Viscoli Claudio,Ruggeri Maurizio,Biagio Antonio Di
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Reference14 articles.
1. European AIDS Clinical Society (EACS). Treatment of HIV-positive pregnant women. Pag 12; Version 7.0, October 2013. Available from: http://www.eacsociety.org/Portals/0/Guidelines_Online_131014.pdf (last access January 2014).
2. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal hiv transmission in the United States. Available from: http://aidsinfo.nih.gov/guidelines/html/3/perinatal-guidelines/0 (last access May 2014).
3. Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years
4. FDA. Clears new formulation of raltegravir for infants. January 2014 Available from: http://www.medscape.com/viewarticle/818946
5. Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected Individuals
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献